Several months ago, the drug company Novartis challenged India’s Patent law to prevent cheaper generic versions of its medicines from being sold in India. This would have threatened India’s ability to produce affordable generic medicines, including HIV medicines that are benefiting millions of people in India and other developing countries.

We are happy to report that, after hundreds of thousands of activists around the world spoke out against Novartis, the Indian courts rejected Novartis’ claim! And better yet, Novartis has announced they will not appeal this ruling. This is a huge victory for poor people around the world.

Your support is making the difference in the lives of millions of poor people around the world. Thank you!

-Tim Fullerton, Oxfam America